National Campaign Launched To Help Increase Diversity In Clinical Trials

Prnewswire: 3/12/14


I’m In campaign to educate underrepresented populations about clinical trial participation


WASHINGTON, March 12, 2014 /PRNewswire/ — The Pharmaceutical Research and Manufacturers of America (PhRMA) and the National Minority Quality Forum today announced a first-of-its-kind national campaign to help increase diversity in clinical trials.

The I’m In campaign will raise awareness about the importance of clinical research and encourage greater participation by diverse patient populations to help researchers develop potential new life-saving medicines. Partnerships with patient advocacy organizations, provider groups, individual physicians, clinical trials sponsors and researchers will help to drive campaign awareness and involvement.

“PhRMA and our member companies are committed to raising awareness and increasing participation in clinical trials, particularly among historically underrepresented populations,” said John Castellani, President and CEO of PhRMA. “Through this collaboration of health care leaders, we are taking a major step forward to help reduce health disparities through greater inclusiveness in clinical research.”

Developing new medicines is a lengthy and complex process, relying heavily on volunteer participation to evaluate potential therapies for safety and effectiveness in clinical studies.  Without the patients who volunteer to participate in clinical trials, the development of new medicines would not be possible. Read More